Join
Live feed
·
PRReleasevia Quantisnow
Forma Therapeutics Holdings Inc. logo

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FMTX (Forma Therapeutics Holdings Inc.) and more on Quantisnow.